Advertisement

Topics

OptiNose UK Ltd Company Profile

04:17 EST 19th December 2018 | BioPortfolio

OptiNose is a drug delivery company with breakthrough technology set to transform the static nasal drug delivery market. The Company was founded in 2000 to commercialize a novel nasal drug delivery system that achieves targeted delivery to sites that are poorly accessed by existing nasal sprays. The technology is unparalleled in its ability to effectively deliver drugs to specific sites within the nose, while uniquely preventing drug distribution to the lungs. This provides significant advantages as rival companies focus principally on formulation-based approaches to nasal delivery; these competing technologies cannot compensate for the poor drug deposition patterns of existing devices.

Location

Berkeley HouseHunts Rise
South Marston Park
Wiltshire
SN3 4TG
United Kingdom

Contact

Phone: 44 (0)179 383 4928
Fax: 44 (0)179 382 5986
Email: info@optinose.co.uk


News Articles [29 Associated News Articles listed on BioPortfolio]

Deals this week: Optinose, Kitov Pharma, Clovis Oncology

Optinose plans to raise funds through an initial public offering of 2.25 million shares of its common stock. The underwriters...Read More... The post Deals this week: Optinose, Kitov Pharma, Clovis On...

OptiNose nets $52.3mm via FOPO

In its first financing since going public, OptiNose Inc. (focused on the ear, nose and throat and allergy space) netted $52.3mm through the follow-on offering of 2.5mm common shares at $22.25 each. St...

OptiNose nets $60.1mm via FOPO

In its first financing since going public, OptiNose Inc. (focused on the ear, nose and throat and allergy space) netted $60.1mm through the follow-on offering of 2.88mm common shares (including full e...

OptiNose, Inc. 2018 Q3 - Results - Earnings Call Slides

Optinose to Highlight Data at Two Upcoming Scientific Meetings

YARDLEY, Pa., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced t...

OptiNose, Inc. 2018 Q2 - Results - Earnings Call Slides

Follow-on roundup: ImmunoGen, Mirati, Zymeworks, OptiNose

Follow-on roundup: ImmunoGen, Mirati, Zymeworks, Viking, OptiNose

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

Efficacy and Safety Study of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi Directional Device in Subjects With Bilateral Nasal Polyposis Followed by an 8-Week Open-Label Extension Phase to

The primary objective of this study is to compare the efficacy of intranasal administration of 100, 200, and 400 μg of fluticasone propionate twice a day delivered by the OptiNose device ...

Study Evaluating the Safety of Intranasal Administration of 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi-Directional Device in Subjects With Chronic Sinusitis With or Without Nasal Polyps

This is an open-label, multicenter study designed to assess the safety of intranasal administration of 400 μg of fluticasone propionate twice a day delivered by the OptiNose device in sub...

Study Evaluating the Efficacy and Safety of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi Directional Device in Subjects With Bilateral Nasal Polyposis Followed by an 8-Week Open-Label Exte

The primary objective of this study is to compare the efficacy of intranasal administration of 100, 200, and 400 μg of fluticasone propionate twice a day delivered by the OptiNose device ...

Companies [2 Associated Companies listed on BioPortfolio]

OptiNose Inc.

OptiNose is a drug delivery company with breakthrough bi-directional nasal technology set to transform the static nasal drug delivery market. Founded in 2000, OptiNose’s devi...

OptiNose UK Ltd

OptiNose is a drug delivery company with breakthrough technology set to transform the static nasal drug delivery market. The Company was founded in 2000 to commercialize a novel nasal drug delivery sy...

More Information about "OptiNose UK Ltd" on BioPortfolio

We have published hundreds of OptiNose UK Ltd news stories on BioPortfolio along with dozens of OptiNose UK Ltd Clinical Trials and PubMed Articles about OptiNose UK Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of OptiNose UK Ltd Companies in our database. You can also find out about relevant OptiNose UK Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record